Providence Hood River, Providence Portland and Providence St. Vincent each earned Healthgrades honors for outstanding patient experience. Providence Medford was honored for patient safety excellence.
New trials available at Earle A. Chiles Research Institute for patients with human epidermal growth factor receptor 2 positive (HER2+) colorectal cancer and patients with cholangiocarcinoma.
In honor of Social Work Month we recognize the incredible contributions of oncology social workers.
Hitting the slopes can be a fun and healthy activity, but there can be risks. Dr. Christopher Van Tilburg, with the Providence Hood River Memorial Hospital Mountain Clinic, talks mountain safety.
A new trial offered at Providence Cancer Institute is enrolling patients with early-stage HR-positive and HER2-negative breast cancer.
Using MRI-guided radiation, Providence radiation oncologists can precisely target tumors for destruction while minimizing damage to surrounding normal tissue.
For third year in a row, Providence St. Vincent Medical Center has received America’s 50 Best Hospitals Award. This recognition places Providence among the top 1% of the country's hospital
A new clinical trial offered at Providence Cancer Institute to study the safety and effectiveness of two different treatments for people under age 70 with previously untreated non-GCB DLBCL.
Providence Cancer Institute highlights a year of engaging with and supporting our patients, partner organizations and community.
Many emergency rooms, clinics and urgent care centers are experiencing a sharp rise in the number of cases of RSV, flu and COVID.
Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.